Chokkalingam A. Risk of total non-hepatic cancer following treatment for HCV infection with direct-acting antiviral agents. PS-155.
PREVAIL IV: vaker ebolavirus-RNA-negatief na behandeling remdesivir
jul 2021 | Virale infecties
jun 2024 | Niertransplantatie, Stamceltransplantatie, Virale infecties